ANTI–IL-13 (CENDAKIMAB) ADMINISTRATION IMPROVES OESOPHAGEAL GENE EXPRESSION IN EOSINOPHILIC OESOPHAGITIS
Julie M. Caldwell 1
Adina Y. Ballaban 1
Jie Li 2
Rachel Maddux 2
Sarah Harris 2
Marc E. Rothenberg 2
1 Cincinnati Children’s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, United States
2 Bristol Myers Squibb, Princeton, United States
Topic
Oesophagus
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]